Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|112|1|60-65

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.112, Iss.1, 2015-07, pp. : 60-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence

By  

Oncology, Vol. 92, Iss. 4, 2017-01 ,pp. : 221-228

Karger

Access to resources Recommend Favorite

Value of Positive Lymph Node Ratio for Predicting Postoperative Distant Metastasis and Prognosis in Esophageal Squamous Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 38, Iss. 9, 2015-0 ,pp. : 424-428

Karger

Access to resources Recommend Favorite

Gli-1 Expression Is Associated with Lymph Node Metastasis and Tumor Progression in Esophageal Squamous Cell Carcinoma

By  

Oncology, Vol. 70, Iss. 5, 2007-01 ,pp. : 378-389

Karger

Access to resources Recommend Favorite

MOR1 in esophageal squamous cell carcinoma

By  

DISEASES OF THE ESOPHAGUS (ELECTRONIC), Vol. 28, Iss. 2, 2015-02 ,pp. : 196-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postoperative Intensity-Modulated Radiotherapy Improved Survival in Lymph Node-Positive or Stage III Thoracic Esophageal Squamous Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 38, Iss. 3, 2015-02 ,pp. : 97-102

Karger

Access to resources Recommend Favorite